Delivery Order SPE2DB20D1100-SPE2DB24FC8U0

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $66K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,668.33, is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of January 27, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,912.10 firm fixed price contract is for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30. The contract has an ultimate completion date of October 17, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $62,073.76, is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,096.32, is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S. The contract has a firm fixed price of $28,043.40 and a period of performance through August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $42,086.28 and has an ultimate completion date of June 20, 2024. The contract provides the DLA with the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $69,199.18, is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of January 2, 2024. The contract is not designated under any set-aside program....
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of BIKTARVY 50-200-25 MG TABLET medical products, with a ceiling value of $36,066.84 and a completion date of February 13, 2025. The contract is a firm fixed price delivery order, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $100,747.77, is for the delivery of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product, to support federal healthcare programs. The contract has a firm fixed price and a completion date of February 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Firm Fixed Price pricing type and a ceiling value of $18,412.08, with an ultimate completion date of June 20, 2024. The contract provides for the delivery of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product, to support military treatment facilities, veterans'...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC8U0
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BIKTARVY 50-200-25 MG TABLET in the amount of $65,788.93. The contract has an ultimate completion date of July 24, 2024 and is a Firm Fixed Price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:12 AM